Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.
Researchers have identified a new class of virus-like agents known as "obelisks" in oral and stool samples from hundred of people.
The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.
The study identified a core microbiota signature that may serve as a health indicator and a therapeutic target.
Standardizing microbiome analysis improves the quality and reliability of data, helping researchers to explore the gut microbiota’s impact on athletes and its relationship with health and performance.
The results also indicate that the hospital environment influences the gut bacteria of preterm infants, highligting the importance of managing antibiotics and medications to support a healthy gut development.
The findings improve our understanding of the genetic complexity of the human gut microbiota and its implications for health.
The findings highlight the complex interactions between some dietary compounds and the gut microbiota, suggesting that microbial variations can impact health in different ways.
The findings highlight the importance of the gut microbiota in gut development and immunity, and they provide insights into how microbiota-based interventions could prevent serious conditions such as NEC.
Many common drugs — including antibiotics — can inhibit the growth of gut bacteria and alter their function.
